中国医药
中國醫藥
중국의약
CHINA MEDICINE
2009年
1期
63-64
,共2页
闫钢%李文广%沈文彬%秦立洪
閆鋼%李文廣%瀋文彬%秦立洪
염강%리문엄%침문빈%진립홍
脾肿瘤%超声检查%磁共振成像
脾腫瘤%超聲檢查%磁共振成像
비종류%초성검사%자공진성상
Metastatic tumors%Ultrasourd examination%Magnetic resonance imaging
目的 探讨转移性脾脏肿瘤的诊断与治疗.方法 回顾性分析15例转移性脾脏肿瘤患者的临床资料并对其诊断、治疗和预后进行分析.结果 15例患者中腹部超声检查的检出率为80.0%(12/15),CT的检出率为92.8%,磁共振成像检出率为100%;单发转移性脾脏肿瘤为33.3%(5/15),转移性脾脏肿瘤伴广泛转移66.7%(10/15).行手术治疗的5例患者术后生存1～2.5年;未行手术的10例患者均于半年或近期内死亡.结论 病史、影像学检查及原发性肿瘤的病理学诊断是转移性脾脏肿瘤的主要诊断依据,治疗方法以手术治疗为主,放射治疗、化学治疗、免疫治疗等为辅的综合治疗.
目的 探討轉移性脾髒腫瘤的診斷與治療.方法 迴顧性分析15例轉移性脾髒腫瘤患者的臨床資料併對其診斷、治療和預後進行分析.結果 15例患者中腹部超聲檢查的檢齣率為80.0%(12/15),CT的檢齣率為92.8%,磁共振成像檢齣率為100%;單髮轉移性脾髒腫瘤為33.3%(5/15),轉移性脾髒腫瘤伴廣汎轉移66.7%(10/15).行手術治療的5例患者術後生存1～2.5年;未行手術的10例患者均于半年或近期內死亡.結論 病史、影像學檢查及原髮性腫瘤的病理學診斷是轉移性脾髒腫瘤的主要診斷依據,治療方法以手術治療為主,放射治療、化學治療、免疫治療等為輔的綜閤治療.
목적 탐토전이성비장종류적진단여치료.방법 회고성분석15례전이성비장종류환자적림상자료병대기진단、치료화예후진행분석.결과 15례환자중복부초성검사적검출솔위80.0%(12/15),CT적검출솔위92.8%,자공진성상검출솔위100%;단발전이성비장종류위33.3%(5/15),전이성비장종류반엄범전이66.7%(10/15).행수술치료적5례환자술후생존1～2.5년;미행수술적10례환자균우반년혹근기내사망.결론 병사、영상학검사급원발성종류적병이학진단시전이성비장종류적주요진단의거,치료방법이수술치료위주,방사치료、화학치료、면역치료등위보적종합치료.
Objective To discuss the diagnosis and treatment of metastatic spleen tumors.Methods Clinical data of 15 cases of metastatic spleen tumors patients was reviewed.Results The detection rate of abdominal uhrasonography,CT and magnetic resonance imaging was 80%,92.8%and 100% respectively in 15 cases.Spleen single metastatic tumors was 33.3%.Spleen metastatic tumors with extensive transfer was 66.7%.5 cases treated with surgery existed from 1 to 2.5 years after operation.10 cases without surgery died in around six months.Conclusion The diagnosis of metastatic spleen tumors is mainly based on patient history,imaging and pathology examination of the primary tumor.Surgery is the major therapy which is usually combine with assistant treatment such as radiotherapy,chemotherapy and immunotherapy.
